Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
31,031
Price
$20.05
Total Value
$622,323.60
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Aug 18, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Aug 19, 2026 |
| Shares Sold | 31,031 |
| Price per Share | $20.05 |
| Total Value | $622,323.60 |
| Shares Owned After | 39,900 |
| Derivative | No |
| Accession Number | 0001810417-26-000019 |
| Document | View SEC Filing |